← Leaderboards
Jack Roth
University Of Texas Md Anderson Can Ctr
$8,028,008
Attributed
$9,745,509
Total exposure
16
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.7M · FY2008–25$10M$7.5M$5M$2.5M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$43,330,742 · 20
By mechanism
P50$20,385,709 · 9
U54$15,030,205 · 8
P01$5,406,537 · 2
R01$2,508,291 · 1
Top collaborators
- Funda Meric-Bernstam9 shared
- John D Minna9 shared
- Trever G Bivona5 shared
- Jian Gu5 shared
- Xifeng Wu4 shared
- Lin Ji3 shared
- John V. Heymach2 shared
- Senthilkumar Damodaran1 shared
Most similar at University Of Texas Md Anderson Can Ctr
Same institution · by research overlap
- Xifeng Wu$28,679,533
- Hagop Kantarjian$4,345,422
- Carol J Etzel$2,640,254
- Stephanie S Watowich$7,000,320
- Colin P Dinney$4,248,660
Others in their field
Top investigators on “Texas”
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Mitchell J Malone · Texas A&M Research Foundation$353,400,900
- Gary D Acton · University Of California-Davis$320,373,312
- Richard A Gibbs · Baylor College Of Medicine$277,873,103
- Daniel Stanzione · Arizona State University$168,178,740
- Kiyoshi Suyehiro · Iodp Management International, Inc$166,539,344
Research focus
TexasUniversitiesMalignant Neoplasm Of LungProgramsResearch PersonnelMolecularUniversity Of Texas M D Anderson Cancer CenterBaseFundingScientistPilot ProjectsBioinformaticsResponseNon-Small-Cell Lung CarcinomaTumorEnvironmentClinical TrialsMentorshipPeer ReviewTranslatingInstitutionCommunicationInnovationBudgets
Grant awards (80)
BAY AREA & ANDERSON TEAM AGAINST ACQUIRED RESISTANCE - U54 PROGRAM (BAATAAR-UP)$1,079,739
U54 · FY2025 · CA
PDX tumor-TME acquired resistance$284,529
U54 · FY2025 · CA · contact PI
BAY AREA & ANDERSON TEAM AGAINST ACQUIRED RESISTANCE - U54 PROGRAM (BAATAAR-UP)$1,030,386
U54 · FY2024 · CA
PDX tumor-TME acquired resistance$279,123
U54 · FY2024 · CA · contact PI
BAY AREA & ANDERSON TEAM AGAINST ACQUIRED RESISTANCE - U54 PROGRAM (BAATAAR-UP)$1,067,511
U54 · FY2023 · CA
PDX tumor-TME acquired resistance$283,621
U54 · FY2023 · CA · contact PI
DRP Core: Developmental Research Program$104,234
P50 · FY2023 · CA · contact PI
CEP Core: Career Enhancement Program$104,234
P50 · FY2023 · CA · contact PI
ARTNet NOSI Supplement$80,750
U54 · FY2023 · CA
BAY AREA & ANDERSON TEAM AGAINST ACQUIRED RESISTANCE - U54 PROGRAM (BAATAAR-UP)$1,119,180
U54 · FY2022 · CA
University of Texas PDX Development and Trial Center$557,633
U54 · FY2022 · CA · contact PI
PDX tumor-TME acquired resistance$355,505
U54 · FY2022 · CA · contact PI
Administrative Core$199,970
U54 · FY2022 · CA · contact PI
University of Texas PDX Development and Trial Center$199,970
U54 · FY2022 · CA · contact PI
CEP Core: Career Enhancement Program$104,233
P50 · FY2022 · CA · contact PI
DRP Core: Developmental Research Program$104,232
P50 · FY2022 · CA · contact PI
Pilot Projects and Trans-Network Activities$82,500
U54 · FY2022 · CA · contact PI
Administrative Core$42,412
U54 · FY2022 · CA · contact PI
Targeting Lung Cancer Vulnerabilities$2,125,682
P50 · FY2021 · CA
University of Texas PDX Development and Trial Center$1,259,703
U54 · FY2021 · CA · contact PI
Pilot Projects and Trans-Network Activities$179,182
U54 · FY2021 · CA · contact PI
Administrative Core$95,794
U54 · FY2021 · CA · contact PI
DRP Core: Developmental Research Program$85,993
P50 · FY2021 · CA · contact PI
CEP Core: Career Enhancement Program$85,992
P50 · FY2021 · CA · contact PI
Targeting Lung Cancer Vulnerabilities$2,203,273
P50 · FY2020 · CA
University of Texas PDX Development and Trial Center$1,280,843
U54 · FY2020 · CA · contact PI
Pilot Projects and Trans-Network Activities$182,766
U54 · FY2020 · CA · contact PI
Evaluating drug combinations, efficacy and adaptive feedback in KRAS inhibition$120,000
U54 · FY2020 · CA · contact PI
Administrative Core$97,880
U54 · FY2020 · CA · contact PI
CEP Core: Career Enhancement Program$87,789
P50 · FY2020 · CA · contact PI
DRP Core: Developmental Research Program$87,789
P50 · FY2020 · CA · contact PI
University of Texas PDX Development and Trial Center$1,447,508
U54 · FY2019 · CA · contact PI
SPORE: Developing New Rationale, Personalized Medicine for Lung Cancer$1,109,454
P50 · FY2019 · CA
Pilot Projects and Trans-Network Activities$205,864
U54 · FY2019 · CA · contact PI
Administrative Core$110,050
U54 · FY2019 · CA · contact PI
University of Texas PDX Development and Trial Center$60,000
U54 · FY2019 · CA · contact PI
Administrative Core$8,572
U54 · FY2019 · CA · contact PI
Pilot Projects and Trans-Network Activities$8,571
U54 · FY2019 · CA · contact PI
SPORE: Developing New Rationale, Personalized Medicine for Lung Cancer$2,299,999
P50 · FY2018 · CA
Epigenetic miRNA, SNP Signatures, and their Functions in Lung Cancer Outcomes$494,883
R01 · FY2018 · CA
Epidemiologic Studies of Germline Polymorphisms in miRNA Pathways: Risk of Lung Cancer Development and Recurrence$447,450
P50 · FY2018 · CA · contact PI
University of Texas PDX Development and Trial Center$175,000
U54 · FY2018 · CA · contact PI
Administrative Core$175,000
U54 · FY2018 · CA · contact PI
University of Texas PDX Development and Trial Center$2,561,686
U54 · FY2017 · CA · contact PI
SPORE: Developing New Rationale, Personalized Medicine for Lung Cancer$2,299,998
P50 · FY2017 · CA
Epigenetic miRNA, SNP Signatures, and their Functions in Lung Cancer Outcomes$479,955
R01 · FY2017 · CA
Pilot Projects and Trans-Network Activities$204,258
U54 · FY2017 · CA · contact PI
Administrative Core$194,699
U54 · FY2017 · CA · contact PI
SPORE: Developing New Rationale, Personalized Medicine for Lung Cancer$2,162,000
P50 · FY2016 · CA
SPORE: Developing New Rationale, Personalized Medicine for Lung Cancer$750,052
P50 · FY2016 · CA
Epigenetic miRNA, SNP Signatures, and their Functions in Lung Cancer Outcomes$494,829
R01 · FY2016 · CA
SPORE: Developing New Rationale, Personalized Medicine for Lung Cancer$2,041,142
P50 · FY2015 · CA
Epigenetic miRNA, SNP Signatures, and their Functions in Lung Cancer Outcomes$519,312
R01 · FY2015 · CA
SPORE: Developing New Rationale, Personalized Medicine for Lung Cancer$2,161,999
P50 · FY2014 · CA
Epigenetic miRNA, SNP Signatures, and their Functions in Lung Cancer Outcomes$519,312
R01 · FY2014 · CA
P-5: Translation of the 3p21.3 Gene FUS1 into Pathway-Targeted Molecular Therapy$282,866
P50 · FY2012 · CA · contact PI
Career Development Program$71,378
P50 · FY2012 · CA · contact PI
Developmental Research Program$71,378
P50 · FY2012 · CA · contact PI
P-5: Translation of the 3p21.3 Gene FUS1 into Pathway-Targeted Molecular Therapy$267,499
P50 · FY2011 · CA · contact PI
Career Development Program$67,525
P50 · FY2011 · CA · contact PI
Developmental Research Program$67,524
P50 · FY2011 · CA · contact PI
P-5: Translation of the 3p21.3 Gene FUS1 into Pathway-Targeted Molecular Therapy$280,501
P50 · FY2010 · CA · contact PI
Career Development Program$70,831
P50 · FY2010 · CA · contact PI
Developmental Research Program$70,831
P50 · FY2010 · CA · contact PI
P-5: Translation of the 3p21.3 Gene FUS1 into Pathway-Targeted Molecular Therapy$279,516
P50 · FY2009 · CA · contact PI
Career Development Program$70,607
P50 · FY2009 · CA · contact PI
Developmental Research Program$70,607
P50 · FY2009 · CA · contact PI
P-5: Translation of the 3p21.3 Gene FUS1 into Pathway-Targeted Molecular Therapy$231,895
P50 · FY2008 · CA · contact PI
Career Development Program$58,603
P50 · FY2008 · CA · contact PI
Developmental Research Program$58,603
P50 · FY2008 · CA · contact PI
RESTORATION OF APOPTOSIS IN CANCER$1,135,263
P01 · FY2003 · CA
RESTORATION OF APOPTOSIS IN CANCER$1,730
P01 · FY2003 · CA
RESTORATION OF APOPTOSIS IN CANCER$1,102,200
P01 · FY2002 · CA
Radiation sensitivity/Apoptosis Induction in Cancer Cells--P53 Restoration$279,549
P01 · FY2002 · CA
Radiation sensitivity/Apoptosis Induction in Cancer Cells--P53 Restoration$279,549
P01 · FY2002 · CA
RESTORATION OF APOPTOSIS IN CANCER$43,500
P01 · FY2002 · CA
RESTORATION OF APOPTOSIS IN CANCER$1,070,099
P01 · FY2001 · CA
Radiation sensitivity/Apoptosis Induction in Cancer Cells--P53 Restoration$279,549
P01 · FY2001 · CA
RESTORATION OF APOPTOSIS IN CANCER$1,038,933
P01 · FY2000 · CA
Radiation sensitivity/Apoptosis Induction in Cancer Cells--P53 Restoration$176,165
P01 · FY2000 · CA